ING Group’s Albany Molecular Research Inc AMRI Stock Holding History

ING Group’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,144	Closed	-$220K	–	957
2017 Q2	$220K	Buy	+10,144	New	+$184K	﹤0.01%	774

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

ING Group's AMRI Position: Q3 2017 in Review

ING Group sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 10,144 shares — an estimated $220K sold.

ING Group first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $220K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

ING Group reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
ING Group sold 10,144 Albany Molecular Research Inc shares in Q3 2017, an estimated $220K.
ING Group first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
ING Group's Albany Molecular Research Inc position peaked at $220K in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on ING Group's 13F filing for Q3 2017, filed 8 Nov 2017.